Daniel Clemens
Vice President of Biology at Cyclarity Therapeutics
Dr. Clemens received his B.S. in biochemistry from the University of California, Los Angeles in 2004 and Ph.D. in biomedical sciences from the University of California, Irvine in 2013. He has participated in every aspect of the biology side of drug development, from in vitro screening through IND-enabling toxicology and pharmacology and regulatory filing. Dr. Clemens is the author on 11 peer-reviewed scientific articles and has authored the Investigator’s Brochure for an anticoagulant currently in clinical trials.
Visit website: https://cyclaritytx.com/team/#daniel
See also:
Cyclarity Therapeutics
- Company developing simple and direct interventions targeting toxic forms of cholesterol for age-related diseases
Details last updated 10-May-2024
Daniel Clemens is also referenced in the following:
Cyclarity Therapeutics
Company developing simple and direct interventions targeting toxic forms of cholesterol for age-related diseases